LY4050784

LY4050784 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY4050784, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]